[Evaluation of a new corticoid for various dermatoses].
Diflucortolone valerate 0.1% (investigational number SH K 183 MB) in the form of a cream was clinically investigated in 41 patients with dermatological disorders. All the patients had been treated previously with other topical preparations, but without success. Complete healing or distinct improvement of the objective and subjective symptoms of the disorders was achieved in 100% of the cases treated with the investigational preparation. No side effects were observed at all.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003872:Dermatitis / Q000188:drug therapy*; D005260:Female; D005448:Fluocortolone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011244:Pregnadienediols / Q000627:therapeutic use*; D014631:Valerates / Q000627:therapeutic use
D011244:Pregnadienediols; D014631:Valerates; D005448:Fluocortolone
Prüfung eines neuen Kortikoids bei verschiedenen dermatosen